It will be doubly important that a Federal/Provincial Government consortium undertake such a bulk buying initiative given the terms of  CETA with the EU and anticipated pressure by the Trump Administration to enhance the intellectual property rule protections that favour the big pharmaceutical companies from competition by generic manufacturers.